Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.
about
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Patient-adjusted versus health professional-adjusted insulin dosing for type 2 diabetes mellitusCommon standards of basal insulin titration in type 2 diabetesPsychometric validation of the Self-Care Inventory-Revised (SCI-R) in UK adults with type 2 diabetes using data from the AT.LANTUS Follow-on study.Efficacy and safety of patient-directed titration of once-daily pre-dinner premixed biphasic insulin aspart 70/30 injection in Japanese type 2 diabetic patients with oral antidiabetic drug failure: STEP-AKITA study.Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes.An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocolSafety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials.Patients with type 2 diabetes mellitus failing on oral agents and starting once daily insulin regimen; a small randomized study investigating effects of adding vildagliptin.Evaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31)Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value.The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargineInsulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trialDiabetes patients' experiences with the implementation of insulin therapy and their perceptions of computer-assisted self-management systems for insulin therapyHypoglycaemia in Type 2 diabetes.Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study.Starting insulin in type 2 diabetes: real-world outcomes after the first 12 months of insulin therapy in a new zealand cohort.Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial.An educational program for insulin self-adjustment associated with structured self-monitoring of blood glucose significantly improves glycemic control in patients with type 2 diabetes mellitus after 12 weeks: a randomized, controlled pilot studyEffects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study.A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine.Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part One: Introduction and Review of Current Products and Guidelines.Evaluation of a Remote Monitoring System for Diabetes Control.Initiating insulin in patients with type 2 diabetes.Insulin glargine in the treatment of type 1 and type 2 diabetes.Real-World Data Collection Regarding Titration Algorithms for Insulin Glargine in Patients With Type 2 Diabetes MellitusDiabetes control among Hispanics in the action to control cardiovascular risk in diabetes trial.The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutideAn RCT Investigating Patient-Driven Versus Physician-Driven Titration of BIAsp 30 in Patients with Type 2 Diabetes Uncontrolled Using NPH Insulin.Common crossroads in diabetes management.Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus.Achieving fasting and postprandial blood glucose control in type 2 diabetes.Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain.Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease.Insulin degludec once-daily in type 2 diabetes: simple or step-wise titration (BEGIN: once simple use).Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practiceInsulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience.Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine.
P2860
Q22241288-DA631B8D-398B-4796-BA1E-12F5E9FC9029Q24202547-24D57487-E793-421E-8C8F-C824B75B1D66Q27009355-E1A6AB66-92B3-44EF-A148-1D86985C1E90Q30538061-6E87D19D-494F-4333-9E38-0DB925A63E00Q33558408-EEC4C372-1A47-481C-9B97-82C87CD6BF43Q33610830-0CB1CDFE-7D13-4B6C-9870-6DA897A48AA9Q33633710-E698F1D8-BA1B-4E52-88D5-CA013CF8DA94Q33680901-DD209A38-4E60-4613-8A5B-8D4FC10FF41BQ33834266-6F200040-0BDF-41BA-B0FC-A91980E0B0F0Q33871459-A2E1B3CC-F498-4C82-AF3B-937B558E1806Q34169097-66262E65-A3BE-472C-A638-972825D60AA3Q34299641-C24C4AF7-F21D-4E38-B1A3-A126D816DFC1Q34449820-78B6992E-CB4E-428D-9B80-88909119FAB9Q34506998-091B3EB6-1458-4AFC-92D1-CF4B4FFEF022Q34543042-EF791BB1-367E-4FC3-9CD2-3C337084E490Q34657801-661B1153-E9F5-4932-94B8-47BDDA7B658BQ34739954-A1A1EF8D-EAD4-4D21-A0FF-5B01E1223110Q34782893-D520C75B-97B8-4D46-9CE5-00C3E5F19B64Q35217922-D0C70D01-55B1-4B52-9C33-1CEEAF10A1E6Q35225372-E1CEB403-6DBB-46B8-A04C-A59B43F45668Q35521033-11C0BE16-51FB-434D-9C3D-3EEC8586F61DQ35673081-3B659F2E-6073-412A-8DE9-2A4692874F86Q35772593-F71A5A45-334A-4D18-B66D-51FE78EB6D7DQ35796626-A4401B09-8FF1-4EB0-AAA0-EE384831476FQ35834639-AE53C2F9-AA43-411A-8E0C-839FB626D7EBQ35894554-89B021D0-2B91-4342-B155-91111EFECBB5Q36012923-877A445B-75F0-4AF0-BAEA-7128F1F02A63Q36057429-39DCB96C-A005-4667-8550-F37D5777945EQ36331397-6B12293F-C37B-4831-AF95-F1232A4A82EAQ36368988-B2F150BB-1323-48BC-962E-855D6D4FDAE0Q36376206-1ADF784C-E3F6-4733-978E-0C6895B8466AQ36511814-7A58277C-8BFD-4688-A371-30302E901DB0Q36521871-8D16A807-DFB8-4D58-BA4A-4FBD34C905F7Q36636422-D630F97E-5C8D-48EC-BC04-3962BAC0BA3BQ36645386-202F8C74-B2DF-415E-8E4E-4876D9912C7DQ36835841-FC07237D-7B4C-4C11-8CA5-EB0F1DF71645Q37061142-6F4FD7EC-4C2A-4A5F-89EC-E12E94563438Q37113227-05D5B1D3-0143-41C1-9532-00CF84D6F6F5Q37199311-A59E888F-8F8D-4291-AE81-2B0FF2F8228BQ37199318-874491CC-6C60-454D-BF42-B4DA1D34F5DC
P2860
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Improvement of glycemic contro ...... rithms using insulin glargine.
@en
Improvement of glycemic contro ...... rithms using insulin glargine.
@nl
type
label
Improvement of glycemic contro ...... rithms using insulin glargine.
@en
Improvement of glycemic contro ...... rithms using insulin glargine.
@nl
prefLabel
Improvement of glycemic contro ...... rithms using insulin glargine.
@en
Improvement of glycemic contro ...... rithms using insulin glargine.
@nl
P2093
P1433
P1476
Improvement of glycemic contro ...... rithms using insulin glargine.
@en
P2093
ATLANTUS Study Group
Fred Storms
Monique Bianchi-Biscay
Ramon Gomis
Simon Shutler
P304
P356
10.2337/DIACARE.28.6.1282
P407
P577
2005-06-01T00:00:00Z